Improving Sleep in Cancer Patients: A Feasibility Trial
Completed · Not applicable
Conditions studied: Cancer, Insomnia
In brief
The purpose of this study is to determine if CBT-I (cognitive behavioral therapy for insomnia) is a feasible treatment for insomnia in individuals undergoing cancer treatment.
Key facts
- Study ID
- NCT03561064
- Run by
- Dartmouth-Hitchcock Medical Center
- People needed
- 10
- Starts
- 2018-04-13
- Expected to finish
- 2019-03-31
- Last updated by the study team
- 2019-04-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18+ years of age
- have insomnia disorder (SOL or WASO greater than 30 minutes for more than 6 nights in two weeks + daytime impairments)
- are diagnosed with gastro-intestinal cancer;
- have life expectancy > 6 months;
- are fully ambulatory indicated by the provider-rated score of greater than 2 on the Eastern Cooperative Oncology Group (ECOG) performance measure;
- will complete cancer treatments in no less than seven weeks, allowing for two weeks of assessments and five weeks of CBT-I;
- are English-speaking and able to provide voluntary, written consent.
You may not qualify if…
- unmanaged sleep apnea indicated by the scores on the STOP-BANG Questionnaire suggesting high risk for sleep apnea and not receiving any sleep apnea treatment;
- other sleep disorders;
- bipolar disorder;
- unmanaged serious mental illnesses;
- suicidal ideation/intent/plan;
- unstabilized pharmacological treatment for insomnia;
- night-shift employment.
Where it is running
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.